Fibroblast  	Fibroblast  	 JJ	B-NP
growth  	growth  	 NN	I-NP
factor-21  	factor-21  	 CD	I-NP
concentration  	concentration  	 NN	I-NP
in  	in  	 IN	O
serum  	serum  	 NN	B-NP
and  	and  	 CC	O
synovial  	synovial  	 JJ	B-NP
fluid  	fluid  	 NN	I-NP
is  	is  	 VBZ	O
associated  	associated  	 VBN	O
with  	with  	 IN	O
radiographic  	radiographic  	 JJ	B-NP
bone  	bone  	 NN	I-NP
loss  	loss  	 NN	I-NP
of  	of  	 IN	O
knee  	knee  	 NN	O
osteoarthritis  	osteoarthritis  	 VBD	O
We  	We  	 PRP	O
aimed  	aimed  	 VBD	O
to  	to  	 TO	O
evaluate  	evaluate  	 VB	O
whether  	whether  	 IN	O
FGF-21  	FGF-21  	 CD	B-NP
concentration  	concentration  	 NN	I-NP
in  	in  	 IN	O
serum  	serum  	 NN	B-NP
and  	and  	 CC	O
synovial  	synovial  	 JJ	B-NP
fluid  	fluid  	 NN	I-NP
( 	( 	 -LRB-	O
SF 	SF 	 NNP	B-NP
)  	)  	 -RRB-	O
is  	is  	 VBZ	O
associated  	associated  	 VBN	O
with  	with  	 IN	O
radiographic  	radiographic  	 JJ	B-NP
bone  	bone  	 NN	I-NP
loss  	loss  	 NN	I-NP
of  	of  	 IN	I-NP
knee  	knee  	 JJ	I-NP
osteoarthritis  	osteoarthritis  	 NNS	I-NP
( 	( 	 -LRB-	O
OA 	OA 	 NNP	B-NP
) 	) 	 -RRB-	O
.  	.  	 .	O
A  	A  	 DT	O
total  	total  	 NN	O
of  	of  	 IN	O
186  	186  	 CD	O
OA  	OA  	 NN	B-NP
patients  	patients  	 NNS	I-NP
and  	and  	 CC	O
108  	108  	 CD	O
controls  	controls  	 NNS	O
were  	were  	 VBD	O
recruited 	recruited 	 VBN	O
.  	.  	 .	O
The  	The  	 DT	O
radiographic  	radiographic  	 JJ	B-NP
bone  	bone  	 NN	I-NP
loss  	loss  	 NN	I-NP
of  	of  	 IN	I-NP
knee  	knee  	 JJ	I-NP
OA  	OA  	 NNP	I-NP
was  	was  	 VBD	O
assessed  	assessed  	 VBN	O
by  	by  	 IN	O
the  	the  	 DT	O
Ahlbäck  	Ahlbäck  	 JJ	B-NP
grading  	grading  	 JJ	I-NP
scale 	scale 	 NN	I-NP
.  	.  	 .	O
FGF-21  	FGF-21  	 NNP	B-NP
concentration  	concentration  	 NN	I-NP
in  	in  	 IN	O
serum  	serum  	 NN	B-NP
and  	and  	 CC	O
SF  	SF  	 NNP	B-NP
was  	was  	 VBD	O
measured  	measured  	 VBN	O
by  	by  	 IN	O
enzyme-linked  	enzyme-linked  	 JJ	B-NP
immunosorbent  	immunosorbent  	 JJ	I-NP
assay  	assay  	 NNS	I-NP
( 	( 	 -LRB-	O
ELISA 	ELISA 	 NNP	B-NP
) 	) 	 -RRB-	O
.  	.  	 .	O
We  	We  	 PRP	O
demonstrated  	demonstrated  	 VBD	O
that  	that  	 IN	O
OA  	OA  	 NNP	B-NP
patients  	patients  	 NNS	I-NP
had  	had  	 VBD	O
significantly  	significantly  	 RB	O
higher  	higher  	 RBR	O
serum  	serum  	 JJ	B-NP
FGF-21  	FGF-21  	 CD	I-NP
concentration  	concentration  	 NN	I-NP
compared  	compared  	 VBN	O
with  	with  	 IN	O
controls  	controls  	 NNS	O
( 	( 	 -LRB-	O
204.30  	204.30  	 NNP	O
[ 	[ 	 -LRB-	O
range  	range  	 NN	O
158.25-279.16 	158.25-279.16 	 CD	O
]  	]  	 -RRB-	O
ng 	ng 	 FW	B-NP
/ 	/ 	 FW	I-NP
L  	L  	 FW	I-NP
vs.  	vs.  	 FW	O
130.72  	130.72  	 FW	O
[ 	[ 	 -LRB-	O
range  	range  	 NN	O
94.93-218.03 	94.93-218.03 	 CD	O
]  	]  	 -RRB-	O
ng 	ng 	 FW	B-NP
/ 	/ 	 FW	I-NP
L 	L 	 NNP	I-NP
,  	,  	 ,	O
p  	p  	 CD	O
< 	< 	 SYM	O
0.01 	0.01 	 CD	O
) 	) 	 -RRB-	O
.  	.  	 .	O
FGF-21  	FGF-21  	 NNP	B-NP
concentration  	concentration  	 NN	I-NP
in  	in  	 IN	O
serum  	serum  	 NN	B-NP
was  	was  	 VBD	O
well  	well  	 RB	O
correlated  	correlated  	 VBN	O
with  	with  	 IN	O
that  	that  	 DT	O
in  	in  	 IN	O
paired  	paired  	 JJ	O
SF  	SF  	 NNP	B-NP
samples  	samples  	 NNS	I-NP
( 	( 	 -LRB-	O
r  	r  	 LS	O
=  	=  	 SYM	O
0.668 	0.668 	 CD	O
,  	,  	 ,	O
p  	p  	 CD	O
< 	< 	 SYM	O
0.001 	0.001 	 CD	O
) 	) 	 -RRB-	O
.  	.  	 .	O
In  	In  	 IN	O
OA  	OA  	 NNP	B-NP
patients 	patients 	 NNS	I-NP
,  	,  	 ,	O
those  	those  	 DT	O
with  	with  	 IN	O
a  	a  	 DT	O
higher  	higher  	 JJR	O
Ahlbäck  	Ahlbäck  	 JJ	B-NP
grade  	grade  	 NN	I-NP
had  	had  	 VBD	O
significantly  	significantly  	 RB	O
higher  	higher  	 JJR	O
serum  	serum  	 NNS	B-NP
and  	and  	 CC	O
SF  	SF  	 NNP	B-NP
FGF-21  	FGF-21  	 NNP	I-NP
concentration  	concentration  	 NN	I-NP
( 	( 	 -LRB-	O
p  	p  	 JJ	O
< 	< 	 SYM	O
0.001  	0.001  	 NN	O
for  	for  	 IN	O
both 	both 	 DT	O
) 	) 	 -RRB-	O
.  	.  	 .	O
FGF-21  	FGF-21  	 NNP	B-NP
concentration  	concentration  	 NN	I-NP
in  	in  	 IN	O
serum  	serum  	 NN	B-NP
and  	and  	 CC	O
SF  	SF  	 NNP	B-NP
was  	was  	 VBD	O
significantly  	significantly  	 RB	O
and  	and  	 CC	O
independently  	independently  	 RB	O
associated  	associated  	 VBN	O
with  	with  	 IN	O
the  	the  	 DT	O
Ahlbäck  	Ahlbäck  	 JJ	B-NP
grade  	grade  	 NN	I-NP
( 	( 	 -LRB-	O
r  	r  	 LS	O
=  	=  	 SYM	O
0.403 	0.403 	 CD	O
,  	,  	 ,	O
p  	p  	 JJ	O
< 	< 	 SYM	O
0.001  	0.001  	 NN	O
and  	and  	 CC	O
r  	r  	 LS	O
=  	=  	 SYM	O
0.410 	0.410 	 CD	O
,  	,  	 ,	O
p  	p  	 CD	O
< 	< 	 SYM	O
0.001 	0.001 	 CD	O
;  	;  	 :	O
respectively 	respectively 	 RB	O
) 	) 	 -RRB-	O
.  	.  	 .	O
These  	These  	 DT	O
findings  	findings  	 NNS	O
indicated  	indicated  	 VBD	O
that  	that  	 IN	O
FGF-21  	FGF-21  	 NNP	B-NP
might  	might  	 MD	O
be  	be  	 VB	O
a  	a  	 DT	O
potential  	potential  	 JJ	B-NP
biomarker  	biomarker  	 NN	I-NP
for  	for  	 IN	I-NP
predicting  	predicting  	 VBG	I-NP
bone  	bone  	 NN	I-NP
loss  	loss  	 NN	I-NP
of  	of  	 IN	I-NP
OA 	OA 	 NNP	I-NP
.  	.  	 .	O
Therapeutic  	Therapeutic  	 JJ	B-NP
interventions  	interventions  	 NNS	I-NP
by  	by  	 IN	O
blocking  	blocking  	 VBG	B-NP
FGF-21  	FGF-21  	 CD	I-NP
signaling  	signaling  	 JJ	O
pathways  	pathways  	 NN	O
to  	to  	 TO	O
delay  	delay  	 VB	O
the  	the  	 DT	O
degenerative  	degenerative  	 JJ	B-NP
process  	process  	 NN	I-NP
of  	of  	 IN	I-NP
OA  	OA  	 NNP	I-NP
warrants  	warrants  	 NNS	I-NP
further  	further  	 JJ	O
investigations 	investigations 	 NNS	B-NP
.  	.  	 .	O
